Radiation Therapy Quality Assurance Phantoms Market to Grow with a CAGR of 6.60% through 2030
The increasing prevalence of cancer is expected to
drive the growth of global Radiation Therapy Quality Assurance Phantoms in the
forecast period, 2026-2030.
According to TechSci Research report, “Radiation Therapy Quality Assurance
Phantoms Market
- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2030” The Global Radiation Therapy Quality Assurance Phantoms Market was valued at USD 100.24 million in 2024 and is expected to reach USD 147.12 million by 2030 with a CAGR of 6.60% during the forecast period. This can be ascribed to the increasing demand
for phantoms for the treatment of cancer along with the severe prevalence of
cancer across the globe. Additionally, increasing demand for better treatment
and increasing burden of different types of cancers like head and neck,
prostate, and lung cancer especially in the developed countries in North
America and Europe is expected to create lucrative opportunities for market
growth in coming years. Besides, increasing research and development activities
in the healthcare industry is further expected to support market growth.
Similarly, the growing demand for tissue equivalent phantoms for the treatment
of skin cancer is anticipated to boost the market growth during the forecast
period. Also, the growing demand for precise calibration techniques for
efficient diagnostic imaging procedures along with advancement in radiation
therapy such as image-guided and intensity-modulated radiation therapy will
further boost the market growth over the years.
However, the high
cost of phantoms along with the lack of skilled professionals slowed down the
growth of The Global Radiation Therapy Quality Assurance Phantoms Market in the
forecast period. Similarly, high risks and complications associated with
radiation treatments may hamper the Radiation Therapy Quality Assurance
Phantoms market growth during the forecast period.
Browse over XX market data
Figures spread through XX
Pages and an in-depth TOC on "Global Radiation Therapy Quality Assurance Phantoms Market"
The global radiation therapy
quality assurance phantoms market is segmented into by technology, therapy,
application, regional distribution, and company.
Based on Therapy, the Image-Guided Radiation Therapy (IGRT) category is showing the fastest growth. This surge is driven by the increasing clinical preference for radiation treatments that combine imaging and therapy for enhanced precision, safety, and adaptability in real-time. IGRT involves the use of advanced imaging technologies—such as CT, MRI, or X-ray—before and during radiation delivery to improve targeting accuracy and reduce damage to surrounding healthy tissue. This is particularly crucial in treating tumors located near critical organs or those that move with respiration, such as lung or prostate cancers. The precision of IGRT enables the delivery of higher doses of radiation with better tumor control while minimizing side effects, thus improving patient outcomes. With the rise of personalized oncology and adaptive radiation therapy, IGRT is becoming a cornerstone in modern cancer treatment. This increasing complexity in radiation therapy necessitates highly sophisticated QA phantoms capable of validating both the imaging systems and the radiation dose delivery mechanisms. QA phantoms tailored for IGRT systems must simulate real anatomical and physiological conditions, including motion, making them more technically advanced and in higher demand.
Based on the Region, Asia Pacific is exhibiting the fastest growth in the Global Radiation Therapy Quality Assurance (QA) Phantoms Market. This growth trajectory is supported by a combination of increasing cancer incidence, expanding healthcare infrastructure, and growing awareness of the need for treatment accuracy in radiotherapy. Countries such as China, India, Japan, and South Korea are making substantial investments in oncology care, including the development of advanced radiation therapy centers that require high-precision quality assurance protocols. One of the key drivers of this regional growth is the rapid modernization of cancer care services, with governments actively promoting early cancer detection and access to advanced treatment modalities. For example, Japan and South Korea have well-established cancer screening programs, while India and China have launched several public and private cancer hospitals with radiotherapy capabilities. As radiotherapy becomes more common in these settings, there is an increasing emphasis on ensuring patient safety and treatment accuracy—thus boosting the demand for QA phantoms.
Major companies operating in the Global Radiation Therapy Quality Assurance Phantoms Market are:
- Computerized Imaging Reference Systems, Inc.
- Fluke Biomedical LLC.
- IBA Dosimetry Gmbh
- Modus Medical Devices Inc.
- PTW Freiburg GmbH
- Standard Imaging Inc.
- Sun Nuclear Corporation.
- The Phantom Laboratory Inc.
- Gammex Inc.
- Gold Standard Phantoms Limited
Download Free Sample Report
Customers can also request for 10% free customization on this report.
“North
America is expected to dominate in The Global Radiation Therapy Quality Assurance
Phantoms Market on account due to increasing the number of major medical
technology companies across the region. Furthermore, increasing the usage of
radiotherapy units along with a growing focus on the development of novel
technologies and systematic radiation therapy for providing better patient care,
growing partnerships and collaboration with the gamma knife manufacturers is
further contributing to the demand for Radiation Therapy Quality Assurance Phantoms.
Besides, the availability of skilled professionals and early adoption of
advanced treatments for different types of cancers in the region and the
development of more effective methods for error reduction and process analysis
such as failure mode for dose mistakes and effect analysis is further expected
to create lucrative opportunities for market growth during the forecast period
2028” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based
global management consulting firm.
“Radiation Therapy Quality Assurance Phantoms Market - Global Industry
Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology (Linear Accelerators, Cobalt-60, High-Dose
Radiation, Low-Dose Radiation), By Therapy (Photon Beam Radiation Therapy,
Advanced 3-D Conformal Radiation Therapy, Image Guided Radiation Therapy,
Intensity-modulated radiation therapy, Volumetric Modulated Arc Therapy,
Intraoperative Radiotherapy, Neutron Beam Therapy, Brachytherapy), By Application
(Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Head, and Neck Cancers,
Skin Cancer, Other), By Region and Competition, 2020-2030F”, has
evaluated the future growth potential of global radiation therapy quality assurance
phantoms market and provides statistics & information on market size,
structure, and future market growth. The report intends to provide cutting-edge
market intelligence and help decision-makers take sound investment decisions.
Besides, the report also identifies and analyzes the emerging trends along with
essential drivers, challenges, and opportunities in the global radiation therapy
quality assurance phantoms market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com